The University of Manchester (UoM) and the Manchester University NHS Foundation Trust (MFT) have signed a Memorandum of Understanding to collaborate more closely on the commercialisation of new innovations and IP.
Teams from University’s Innovation Factory, academics, MFT clinicians and the MFT’s commercialisation team are now working together to accelerate the commercialisation of new IP capable of generating significant beneficial social, clinical and economic impact.
The collaboration will allow the organisations to share best practices, improve project management and communications as well as provide clarity on project leadership for investors, licensees, industrial partners and other stakeholders.
Teams from UoM and MFT will meet regularly to share information and decide on the best approach to take a new innovation to market. They are also planning a series of events to encourage clinicians and researchers to share their new innovative ideas.
Andrew Wilkinson, CEO of the University of Manchester Innovation Factory comments: “By working more closely together to commercialise new innovative technology and ideas, we will be better placed to deliver significant benefits to patients, not just within the NHS, but throughout the world.”
